Yunlu Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yunlu Jiang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Bingyuan Ji
School of Mental Health, Shandong Key Laboratory of Behavioral Medicine, Jining Medical University, No. 133 Hehua Road, Jining, PR China
1 shared publication - Bo Bai
Neurobiology Institute, Jining Medical University, Jining, Shandong 272067, P.R. China
1 shared publication - Hai Lu
Fudan University, Jining Medical University, China
1 shared publication Haiqing Liu
Department of Physiology, School of Basic Medical Sciences (Institute of Basic Medical Sciences), Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250024, China
1 shared publication- Haiqing Liu
Department of Physiology, School of Basic Medical Sciences (Institute of Basic Medical Sciences), Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250024, China
1 shared publication - Jing Chen
Neurobiology Key Laboratory of Jining Medical University, Jining, China
1 shared publication
Latest Publications
- Open Access
- 11 September 2023
- Published by Elsevier in Neuropeptides
- Vol. 102, 102382
The regulatory effects of the apelin/APJ system on depression: A prospective therapeutic target
- 11 September 2023
- Published by Elsevier in Neuropeptides
- Vol. 102, 102382
Open AccessThe regulatory effects of the apelin/APJ system on depression: A prospective therapeutic target
- 1 November 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1863 (11) , 2719-2738
Heterodimerization of the kappa opioid receptor and neurotensin receptor 1 contributes to a novel β-arrestin-2–biased pathway
- 1 November 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1863 (11) , 2719-2738
Heterodimerization of the kappa opioid receptor and neurotensin receptor 1 contributes to a novel β-arrestin-2–biased pathway